BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beg MS, Huang X, Silvers MA, Gerber DE, Bolluyt J, Sarode V, Fattah F, Deberardinis RJ, Merritt ME, Xie XJ, Leff R, Laheru D, Boothman DA. Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer. J Surg Oncol 2017;116:83-8. [PMID: 28346693 DOI: 10.1002/jso.24624] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Löcken H, Clamor C, Müller K. Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells. J Nat Prod 2018;81:1636-44. [DOI: 10.1021/acs.jnatprod.8b00247] [Reference Citation Analysis]
2 Alexander MS, Cullen JJ. Treating pancreatic cancer: more antioxidants more problems? Expert Rev Gastroenterol Hepatol 2018;12:849-51. [PMID: 29956580 DOI: 10.1080/17474124.2018.1494572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Zhang K, Chen D, Ma K, Wu X, Hao H, Jiang S. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer. J Med Chem 2018;61:6983-7003. [DOI: 10.1021/acs.jmedchem.8b00124] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 13.5] [Reference Citation Analysis]
4 Löcken H, Clamor C, Müller K. Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells. J Nat Prod 2018;81:1636-44. [DOI: 10.1021/acs.jnatprod.8b00247] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
5 Zhong B, Yu J, Hou Y, Ai N, Ge W, Lu JJ, Chen X. A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis. Free Radic Biol Med 2021;166:104-15. [PMID: 33600944 DOI: 10.1016/j.freeradbiomed.2021.02.014] [Reference Citation Analysis]
6 Melstrom LG, Singh G, Fong Y. Accelerating progress in the fight against pancreatic cancer Proceedings of the 2017 Leo and Anne Albert Symposium for Pancreatic Cancer Research. J Surg Oncol 2017;116:5-6. [PMID: 28608945 DOI: 10.1002/jso.24672] [Reference Citation Analysis]
7 Hosein AN, Beg MS. Pancreatic Cancer Metabolism: Molecular Mechanisms and Clinical Applications. Curr Oncol Rep 2018;20:56. [PMID: 29752600 DOI: 10.1007/s11912-018-0699-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
8 Shokati Eshkiki Z, Khayer N, Talebi A, Karbalaei R, Akbari A. Novel insight into pancreatic adenocarcinoma pathogenesis using liquid association analysis. BMC Med Genomics 2022;15:30. [PMID: 35180880 DOI: 10.1186/s12920-022-01174-3] [Reference Citation Analysis]
9 Zhao W, Jiang L, Fang T, Fang F, Liu Y, Zhao Y, You Y, Zhou H, Su X, Wang J, Liu S, Chen Y, Wan J, Huang X. β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation. Front Oncol 2021;11:747282. [PMID: 34676172 DOI: 10.3389/fonc.2021.747282] [Reference Citation Analysis]
10 Van Sciver RE, Lee MP, Lee CD, Lafever AC, Svyatova E, Kanda K, Colliver AL, Siewertsz van Reesema LL, Tang-Tan AM, Zheleva V, Bwayi MN, Bian M, Schmidt RL, Matrisian LM, Petersen GM, Tang AH. A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology. Cancers (Basel) 2018;10:E142. [PMID: 29757973 DOI: 10.3390/cancers10050142] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
11 Singh N, Pay SL, Bhandare SB, Arimpur U, Motea EA. Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy. Cancers (Basel) 2020;12:E972. [PMID: 32295316 DOI: 10.3390/cancers12040972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Floberg JM, Wang L, Bandara N, Rashmi R, Mpoy C, Garbow JR, Rogers BE, Patti GJ, Schwarz JK. Alteration of Cellular Reduction Potential Will Change 64Cu-ATSM Signal With or Without Hypoxia. J Nucl Med 2020;61:427-32. [PMID: 31586008 DOI: 10.2967/jnumed.119.230805] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
13 Garavaglia PA, Rubio MF, Laverrière M, Tasso LM, Fichera LE, Cannata JJB, García GA. Trypanosoma cruzi : death phenotypes induced by ortho -naphthoquinone substrates of the aldo-keto reductase ( Tc AKR). Role of this enzyme in the mechanism of action of β -lapachone. Parasitology 2018;145:1251-9. [DOI: 10.1017/s0031182018000045] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Lin SY, Syu JP, Lo YT, Chau YP, Don MJ, Shy HT, Lai SM, Kung HN. Mitochondrial activity is the key to the protective effect of β-Lapachone, a NAD+ booster, in healthy cells against cisplatin cytotoxicity. Phytomedicine 2022;101:154094. [PMID: 35447421 DOI: 10.1016/j.phymed.2022.154094] [Reference Citation Analysis]
15 Nagaraju GP, Farran B, Farren M, Chalikonda G, Wu C, Lesinski GB, El-Rayes BF. Napabucasin (BBI 608), a potent chemoradiosensitizer in rectal cancer. Cancer 2020;126:3360-71. [PMID: 32383803 DOI: 10.1002/cncr.32954] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Narayanan D, Ma S, Özcelik D. Targeting the Redox Landscape in Cancer Therapy. Cancers (Basel) 2020;12:E1706. [PMID: 32605023 DOI: 10.3390/cancers12071706] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
17 Dias RB, de Araújo TBS, de Freitas RD, Rodrigues ACBDC, Sousa LP, Sales CBS, Valverde LDF, Soares MBP, dos Reis MG, Coletta RD, Ramos EAG, Camara CA, Silva TMS, Filho JMB, Bezerra DP, Rocha CAG. β-Lapachone and its iodine derivatives cause cell cycle arrest at G2/M phase and reactive oxygen species-mediated apoptosis in human oral squamous cell carcinoma cells. Free Radical Biology and Medicine 2018;126:87-100. [DOI: 10.1016/j.freeradbiomed.2018.07.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
18 Torrente L, Prieto-Farigua N, Falzone A, Elkins CM, Boothman DA, Haura EB, DeNicola GM. Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone. Redox Biol 2020;30:101440. [PMID: 32007910 DOI: 10.1016/j.redox.2020.101440] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]